Skip to main content
. 2021 Oct 29;17(12):5016–5023. doi: 10.1080/21645515.2021.1992212

Table 1.

Characteristics of patients with lung cancer or pulmonary ground-glass opacity (GGO)

  Subgroup analysis by diagnosis
(n, %)
Subgroup analysis by willingness
(n, %)
  GGO Lung cancer P High Low P
Age (Mean±SD) 49.6 ± 9.9 50.1 ± 9.7 0.706 50.4 ± 9.2 49.3 ± 10.4 0.295
Gender     <0.001     <0.001
Male 49 (23.3) 47 (41.2)   62 (41.1) 34 (19.7)  
Female 161 (76.7) 67 (58.8)   89 (58.9) 139 (80.3)  
Education level     0.297     0.819
Middle school diploma or below 24 (11.4) 23 (20.2)   20 (13.3) 27 (15.6)  
High school diploma or equivalent 96 (45.7) 44 (38.6)   67 (44.4) 73 (42.2)  
College diploma and above 90 (42.9) 47 (41.2)   64 (42.4) 73 (42.2)  
Comorbidities            
Hx of allergy to drug/food 14 (6.7) 12 (10.5) 0.222 14 (9.3) 12 (6.9) 0.4402
Hx of allergy to vaccine/s 0 0 0 0
Hypertension 35 (16.7) 13 (11.4) 0.203 20 (13.3) 28 (16.2) 0.457
Diabetes mellitus 7 (3.3) 5 (4.4) 0.759* 9 (5.2) 3 (2.0) 0.126*
Coronary artery diseases 3 (1.4) 1 (0.9) 1.000* 2 (1.2) 2 (1.3) 1.000*
Chronic dermatosis 10 (4.8) 3 (2.6) 0.555* 6 (4.0) 7 (4.1) 0.974
COPD 0 0 0 0
Chronic communicable diseases 6 (2.9) 9 (7.9) 0.039 7 (4.6) 8 (4.6) 0.996
Hematological malignancy 0 0 0 0
Immunodeficiency diseases 1 (0.5) 0 1.000* 0 1 (0.6) 1.000*
Other Hx of malignancy 24 (11.4) 9 (7.9) 0.315 12 (8.0) 21 (12.1) 0.013
Diagnosis         <0.001
GGO 210 (100) 0   113 (74.8) 97 (56.1)  
Lung cancer 0 114 (100)   38 (25.2) 76 (43.9)  
Willingness for vaccination     <0.001    
Completely refuse 6 (2.9) 14 (12.3)   20 (7.6)  
Hesitant 91 (43.3) 62 (54.4)   153 (58.4)  
Acceptable 40 (19.0) 23 (20.2)   63 (41.7)  
Intend to receive 18 (8.6) 8 (7.0)   26 (17.2)  
Already vaccinated 55 (26.2) 7 (6.1)   62 (41.1)  

*Fisher’s exact test. GGO, ground-glass opacity; COPD, chronic obstructive pulmonary disease; SD, standard deviation; Hx, history.